4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE

未知生产厂商

技术标识符

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Process for the preparation of imatinib and intermediates thereof
- US 8168787 B2
  申请人: FALCHI ALESSANDRO优先权: 2006
  US
  4 件公开
- CN 101528700 B
  申请人: ITALIANA SINT SPA优先权: 2007
  CN
Salt Forms of 4- (4-Methylpiperazin-1-Ylmethyl) -N- [4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl]- Benzamide
US 2008249104 A1申请人: BURGER HANS MICHAEL优先权: 2008
US
4 件公开
Pharmaceutical composition for treatment or remission of chronic myelogenous leukemia
US 11185517 B2申请人: DELTA FLY PHARMA INC优先权: 2016
CN
US
2 件公开
Multicomponent crystals comprising imatinib mesilate and selected co-crystal formers
US 9221789 B2申请人: BASF SE优先权: 2013
US
2 件公开
Acid addition salts of imatinib and formulations comprising the same
EP 2062885 A1申请人: ECZACIBASI ZENTIVA KIMYASAL UE优先权: 2007
EP